Human induced pluripotent stem cells (iPSCs) have unlimited proliferation capability and
potential to differentiate into all somatic cells. Their derivatives contain patients' genetic …

Induced pluripotent stem cells (iPSCs) can be produced from various somatic cells and have
the ability to differentiate into various cells and tissues of the body. Regenerative medicine …

The development of induced pluripotent stem cell (iPSC) technology has generated
enthusiasm about the therapeutic potential of these cells for treating a variety of diseases …

NKT cells demonstrate antitumor activity when activated to produce Th1 cytokines by DCs
loaded with α-galactosylceramide, the prototypic NKT cell–activating glycolipid antigen …

The recent generation of induced pluripotent stem cells (iPSCs) from somatic cells provides
an invaluable resource for drug or toxicology screening, medical research, and patient …

Human induced pluripotent stem cells (iPSCs) have emerged as an alternative source of
pluripotent stem cells that can be used for tissue regeneration in place of the controversial …

The tumorigenicity and toxicity of induced pluripotent stem cells (iPSCs) and their derivatives
are major safety concerns in their clinical application. Recently, we developed granulocyte …

Recent progresses in the field of Induced Pluripotent Stem Cells (iPSCs) have opened up
many gateways for the research in therapeutics. iPSCs are the cells which are …

Achievement of immunocompetent and therapeutic T lymphopoiesis from pluripotent stem
cells (PSCs) is a central aim in T cell regenerative medicine. To date, preferentially …

Over the last few years, the generation of induced pluripotent stem cells (iPSCs) from human
somatic cells has proved to be one of the most potentially useful discoveries in regenerative …